Vaccine News and Research

Latest Vaccine News and Research

COVID mRNA vaccines induce antibodies against three SARS-CoV-2 variants

COVID mRNA vaccines induce antibodies against three SARS-CoV-2 variants

Scientists reveal the role of newly introduced lineages in COVID-19 resurgence in Europe

Scientists reveal the role of newly introduced lineages in COVID-19 resurgence in Europe

Study highlights changes within SARS-CoV-2 variants that could be exploited to design effective inhibitors

Study highlights changes within SARS-CoV-2 variants that could be exploited to design effective inhibitors

First demonstration of COVID-19-like response by an essential virus encoded protein by SARS-CoV-2 in vivo

First demonstration of COVID-19-like response by an essential virus encoded protein by SARS-CoV-2 in vivo

Behavior modification key to prevent COVID-19, study shows

Behavior modification key to prevent COVID-19, study shows

Novel candidate malaria vaccine confers high levels of durable protection

Novel candidate malaria vaccine confers high levels of durable protection

Antibody development against SARS-CoV-2 following Moderna vaccine

Antibody development against SARS-CoV-2 following Moderna vaccine

Moderna's COVID vaccine effective against emerging variants including Delta

Moderna's COVID vaccine effective against emerging variants including Delta

Study provides important insights into early stages of SARS-CoV-2 infection

Study provides important insights into early stages of SARS-CoV-2 infection

Sanaria researchers make progress in the development of highly protective malaria vaccine

Sanaria researchers make progress in the development of highly protective malaria vaccine

Intranasal COVID-19 vaccine developed from bacterial extracellular vesicle induces robust antibody response in preclinical trials

Intranasal COVID-19 vaccine developed from bacterial extracellular vesicle induces robust antibody response in preclinical trials

Is the SARS-CoV-2 delta variant threatening vaccine efficacy?

Is the SARS-CoV-2 delta variant threatening vaccine efficacy?

Assessing the safety of inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy children and adolescents

Assessing the safety of inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy children and adolescents

Study shows SARS-CoV-2 breakthrough infections fewer among fully vaccinated

Study shows SARS-CoV-2 breakthrough infections fewer among fully vaccinated

New biomarkers can predict HIV remission after antiretroviral therapy interruption

New biomarkers can predict HIV remission after antiretroviral therapy interruption

Widespread SARS-CoV-2 mutation escapes vaccine- and infection-induced CD8 T-cell responses

Widespread SARS-CoV-2 mutation escapes vaccine- and infection-induced CD8 T-cell responses

More evidence that mixing COVID-19 vaccines may help elicit a robust immune response

More evidence that mixing COVID-19 vaccines may help elicit a robust immune response

Early testing can help mitigate blood clots related to AstraZeneca/Oxford vaccine

Early testing can help mitigate blood clots related to AstraZeneca/Oxford vaccine

Nanotechnology and the fight against COVID-19

Nanotechnology and the fight against COVID-19

Without enough boots on the ground, California’s vaccination efforts falter

Without enough boots on the ground, California’s vaccination efforts falter

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.